KG Hospital in Coimbatore performs India's first minimally invasive triple bypass and valve replacement
KG Hospital has performed India's first minimally invasive surgery recently, combining triple vessel bypass and heart valve replacement.
The team operated on a 60-year-old athletic coach, Mr. K.S. Muhammad Nizamuddin, who was diagnosed with both valvular heart disease and coronary artery blockages. The simultaneous treatment of two complex heart conditions was performed through a small 16 cm by 7 cm incision on the left side of the chest, avoiding traditional open-heart methods.
The surgery was led by Dr. Arun Kumar, a Senior Consultant in cardiothoracic surgery and a specialist in robotic and minimally invasive procedures, who was inspired by a Ukrainian surgeon who has performed 17 such cases globally.
According to Dr. Arun Kumar, avoiding sternum cutting allowed the team to perform the surgery with minimal invasion and a smoother recovery. The patient began walking just five days after the operation and resumed his regular activities within a month. Dr. G. Bakthavathsalam, Chairman of KG Hospital, stated that this is the first time in India that minimally invasive cardiac surgery (MICS procedure) has been performed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
29-05-2025
- The Hindu
KG Hospital in Coimbatore performs India's first minimally invasive triple bypass and valve replacement
KG Hospital has performed India's first minimally invasive surgery recently, combining triple vessel bypass and heart valve replacement. The team operated on a 60-year-old athletic coach, Mr. K.S. Muhammad Nizamuddin, who was diagnosed with both valvular heart disease and coronary artery blockages. The simultaneous treatment of two complex heart conditions was performed through a small 16 cm by 7 cm incision on the left side of the chest, avoiding traditional open-heart methods. The surgery was led by Dr. Arun Kumar, a Senior Consultant in cardiothoracic surgery and a specialist in robotic and minimally invasive procedures, who was inspired by a Ukrainian surgeon who has performed 17 such cases globally. According to Dr. Arun Kumar, avoiding sternum cutting allowed the team to perform the surgery with minimal invasion and a smoother recovery. The patient began walking just five days after the operation and resumed his regular activities within a month. Dr. G. Bakthavathsalam, Chairman of KG Hospital, stated that this is the first time in India that minimally invasive cardiac surgery (MICS procedure) has been performed.
New Indian Express
27-05-2025
- New Indian Express
As Ukrainian POWs die in Russian prisons, autopsies point to a system of brutality
KYIV: 'Everything will be all right.' Ukrainian soldier Serhii Hryhoriev said this so often during brief phone calls from the front that his wife and two daughters took it to heart. His younger daughter, Oksana, tattooed the phrase on her wrist as a talisman. Even after Hryhoriev was captured by the Russian army in 2022, his anxious family clung to the belief that he would ultimately be OK. After all, Russia is bound by international law to protect prisoners of war. When Hryhoriev finally came home, though, it was in a body bag. A Russian death certificate said the 59-year-old died of a stroke. But a Ukrainian autopsy and a former POW who was detained with him tell a different story about how he died – one of violence and medical neglect at the hands of his captors. Hryhoriev is one of more than 200 Ukrainian POWs who have died while imprisoned since Russia's full-scale invasion three years ago. Abuse inside Russian prisons was likely a contributing factor in many of these deaths, according to officials from human rights groups, the U.N., the Ukrainian government and a Ukrainian medical examiner who has performed dozens of POW autopsies. The officials say the prison death toll adds to evidence that Russia is systematically brutalizing captured soldiers. They say forensic discrepancies like Hryhoriev's, and the repatriation of bodies that are mutilated and decomposed, point to an effort to cover up alleged torture, starvation and poor health care at dozens of prisons and detention centers across Russia and occupied Ukraine. Russian authorities did not respond to requests for comment. They have previously accused Ukraine of mistreating Russian POWs — allegations the U.N. has partially backed up, though it says Ukraine's violations are far less common and severe than what Russia is accused of.
&w=3840&q=100)
Business Standard
24-05-2025
- Business Standard
Venus Remedies gets GMP renewal certification from Ukraine's SMDC
Pharma major Venus Remedies on Saturday said it has successfully renewed its good manufacturing practices (GMP) certification from Ukraine's State Service on Medicines and Drugs Control (SMDC). The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh, covering its cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral production lines, including liquid and lyophilized injections, Venus Remedies said in a statement. "Renewal of the Ukrainian GMP certification underlines our unwavering commitment to maintaining world-class manufacturing standards. This milestone not only reinforces our foothold in the Ukrainian market but also facilitates deeper penetration into PIC/S markets, significantly enhancing our international growth prospects," Venus Remedies President, Global Critical Care, Saransh Chaudhary said. Ukraine, being a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consortium, comprising 56 countries spanning Europe, Asia, Oceania, and the Americas, further amplifies the global acceptance and strategic importance of this certification. Venus Remedies already has a robust presence in 32 PIC/S countries, including South Africa, Thailand, Malaysia, Saudi Arabia, and Australia, with plans for continued expansion, it said. The Ukrainian pharmaceutical market, projected to grow at a CAGR (compound annual growth rate) of 3.9 per cent and reach USD 822.26 million by 2029, is driven largely by increased demand for generics and oncology treatments. Venus Remedies, with over two decades of experience in Ukraine and 44 product registrations to date, views this certification as pivotal for sustained growth and expanded access within the broader Asia Commonwealth of Independent States (CIS) region. Aditi K Chaudhary, President, International Business, Venus Remedies Ltd, said, "Ukraine continues to be a key strategic market for us. This renewed GMP certification enhances our credibility with regulators and partners across the region, enabling us to deepen our market presence, expand product portfolios, and provide high-quality medicines to a wider patient base". (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
